Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats

Allergology International

Volumn 55, Issue 3, 2006, Pages 279-286

  Kitamura, Yoshiaki ^a   Das, Asish K ^a   Murata, Yuki ^a   Maeyama, Kazutaka ^b   Dev, Shrabanti ^a   Wakayama, Yousuke ^a   Kalubi, Bukasa ^a   Takeda, Noriaki ^a   Fukui, Hiroyuki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergy; Dexamethasone; HDC; Histamine; Rats

Indexed keywords

DEXAMETHASONE; HISTAMINE; HISTIDINE DECARBOXYLASE; MESSENGER RNA; TOLUENE DIISOCYANATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; NOSE MUCOSA; NOSE PROVOCATION TEST; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINORRHEA; SNEEZING; UPREGULATION;

EID: 33748930011     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.279     Document Type: Article

References (43)

1. Kenneth SB, William ES. Histamine, bradykinin and their antagonists; In: Goodman & Gilman (ed). The pharmacological basis of therapeutics, 9th edition. New York: McGraw-Hill, 1996:581-600.
2. Zahow CA, Panula P, Yamatodani A, Millhorn DE. Glucocorticoid hormones downregulate histidine decarboxylase mRNA and enzyme activity in rat lung. Am. J. Phy. 1998;275:407-413.
3. Taguchi Y, Watanabe T, Kubota H, Hayashi H, Wada H. Purification of histidine decarboxylase from the liver of fetal rats and its immunochemical and immunohistochemical characterization. J. Biol. Chem. 1984;259:5214-5221.
4. Ohmori E, Fukui T, Imanishi N, Yatsunami K, Ichikawa A. Purification and characterization of 1-histidine decarboxylase from mouse mastocytoma P-815 cells. J. Biochem. 1990;107:834-839.
5. Joseph DR, Sullivan PM, Wang YM et al. Characterization and expression of the complementary DNA encoding rat histidine decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 1990;87:733-737.
6. Yamamoto J, Fukui T, Suzuki K, Tanaka S, Yatsunami K, Ichikawa A. Expression and characterization of recombinant mouse mastocytoma histidine decarboxylase. Biochim. Biophys. Acta 1993;1216:431-440.
7. Tanaka S, Fukui T, Yamamoto J et al. Processing and activation of recombinant mouse mastocytoma histidine decarboxylase in the particulate fraction of Sf9 cells by porcine pancreatic elastase. Biochem. Biophys. Acta 1995;1253:9-12.
8. Tanaka S, Nemoto K, Yamamura E, Ichikawa A. Intracellular localization of the 74- and 53-kDa forms of L-histidine decarboxylase in a rat basophilic/mast cell line, RBL-2H3. J. Biol. Chem. 1998;273:8177-8182.
9. Lew W, Oppenheim JJ, Matsushima K. Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by the glucocorticoid hormone. J. Immunology 1988;140:1895-1902.
10. Bochner BS, Rutledge BK, Schleimer RP. Interleikin production by human lung tissue. II. inhibition by antiinflammatory steroid. J. Immunology 1987;139:2303-2307.
11. Beutler B, Krochin BN, Milsark IW, Leudke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986;232:977-980.
12. Bussolino F, Breviario F, Tetta C, Agllietta M, Mantovani A, Dejana E. Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J. Clin. Invest. 1986;77:2027-2033.
13. Ohuchi K, Hirasawa N, Takeda H, Asano K, Wantabe M, Tsurufuji S. Mechanism of antianaphylactic action of beta agonists in allergic inflammation of air pouch type in rats. Int. Arch. Allergy Appl. Immunology 1987;82:26-32.
14. Abe Y, Takeda N, Irifune M et al. Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs. Acta Otolaryngol. 1992;112:703-709.
15. Kalubi B, Takeda N, Irifune M et al. Nasal mucosa sensitization with toluene diisocyanate (TDI) increases preprotachykinin A(PPTA) and preproCGRP mRNAs in guinea pig trigeminal ganglion neurons. Brain Res. 1992;576:287-296.
16. Tanaka K, Okamoto Y, Nagaya Y et al. A nasal allergy model developed in the guinea pig by intranasal application of 2, 4-toluene diisocyanate. Int. Arch. Allergy Appl. Immunol. 1998;85:392-397.
17. Yamada M, Watanabe T, Harino S, Fukui H, Wada H. The effects of protease inhibitors on histidine decarboxylase activities and assay of enzyme in various rat tissues. Biochim. Biophys. Acta 1980;615:458-464.
18. Yamatodani A, Fukuda H, Wada H, Iwaeda T, Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J. Chromatogr. 1985;344:115-123.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265-275.
20. Kubo N, Hori Y, Tomoda K, Yamashita T, Kumazawa T. Histamine content and histamine Hi receptor in experimentally-induced nasal hypersensitivity. Acta Otolaryngol. Suppl. 1989;463:21-28.
21. Abe Y, Ogino S, Irifune M et al. Histamine content, synthesis and degradation in nasal mucosa and lung of guinea-pigs treated with toluene diisocyanate (TDI). Clin. Exp. Allergy 1993;23:512-517.
22. Andrade MVM, Hiragun T, Beaven MA. Dexamethasone Suppresses Antigen-Induced Activation of Phosphatidylinositol 3-kinase and Downstream Responses in Mast Cells. J. Immunology 2004;172:7254-7262.
23. Sengoku T, Kishi S, Sakuma S, Ohkubo Y, Goto T. FK 506 inhibition of histamine release and cytokine production by mast cells and basophils. Int. J. Immunopharmacol. 2000;22:189-201.
24. Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 2000;18:309-345.
25. Smith SJ, Piliponsky AM, Rosenhead F et al. Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood-derived mast cells. Clin. Exp. Allergy 2002;32:906-913.
26. Yamaguchi M, Hirai K, Komia A et al. Regulation of mouse mast cell surface FcεRI expression by dexamethasone. Int. Immunol. 2001;13:843-851.
27. Hirata N, Takeuchi K, Ukai K, Sakakura Y. Expression of histidine decarboxylase messenger RNA and histamine N-methyltransferase messenger RNA in nasal allergy. Clin. Exp. Allergy 1999;29:76-83.
28. Yamauchi K, Mamune-Sato R, Tanno Y et al. Molecular biological aspects of human 1-histidine decarboxylase. In: Garcia-Caballero M, Brandes LJ, Hosoda S(eds). Histamine in normal and cancer cell proliferation. Its importance in basic and clinical research. Oxford: Pergamon Press Ltd, 1993;177-196.
29. Minar JN, Yamamoto KR. Regulatory crosstalk at composite response elements. Trends Biochem. Sci. 1991;16:423-426.
30. Hirasawa N, Funaba Y, Hirano Y et al. Inhibition by dexamethasone of histamine production in allergic inflammation in rats. J. Immunol. 1990;145:3041-3046.
31. Imanishi N, Nakayama T, Asano M, Yatsunami K, Tomita K, Ichikawa A. Induction of histidine decarboxylase by Dexamethasone in mastocytoma P-815 cells. Biochim. Biophys. Acta 1987;928:227-234.
32. Schayer RW, Reilly MA. Studies on the mechanism of activation and deactivation of histidine decarboxylase. Eur. J. Pharmacol. 1972;20:271-280.
33. Maeda K, Taniguchi H, Ohno I et al. Induction of L-histidine decarboxylase in human mast cell line, HMC-1. Exp. Hematology 1998;26:325-331.
34. Mamune-Sato R, Yamauchi K, Ohkawara Y et al. Functional analysis of alternatively spliced transcripts of the human histidine decarboxylase gene and its expression in human tissues and basophilic leukemia cells. Eur. J. Biochem. 1992;209:533-539.
35. Hirasawa N, Murakami A, Ohuchi K. Expression of 74-kDa histidine decarboxylase protein in a macrophage-like cell line RAW 264.7 and inhibition by dexamethasone. Eur. J. Pharmacol. 2001;418:23-28.
36. Ohgoh M, Yamamoto J, Kawata M, Yamamura I, Fukui T, Ichikawa A. Enhanced expression of the mouse L-histidine decarboxylase gene with a combination of dexamethasone and 12-O-tetradecanoylphorbol-13-acetate. Biochem. Biophys. Res. Commun. 1993;196:1113-1119.
37. Ohmori E, Imanishi N, Yatsunami K, Fukui T, Ichikawa A. Fluctuation of fetal rat hepatic histidine decarboxylase activity through the glucocorticoid-ACTH system. Biochim. Pharmacol. 1991;41:844-847.
38. Kawai H, Ohgoh M, Emoto S et al. Synergistic effects of 12-o-tetradecanoylphorbol-13-acetate and Dexamethasone on de novo synthesis of histidine decarboxylase in mouse mastocytoma P-815 cells. Biochem. Biophys. Acta 1992;1133:172-178.
39. Takamatsu S, Nakashima I, Nakano K. Modulation of endotoxin-induced histamine synthesis by cytokine in mouse bone marrow-derived macrophages. J. Immunol. 1996;156:778-785.
40. Shiraishi M, Hirasawa N, Oikawa S, Kobayashi Y, Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000;99:600-606.
41. Aoi R, Nakashima I, Kitamura Y, Asai H, Nakano K. Histamine synthesis by mouse T lymphocytes through induced histidine decarboxylase. Immunology 1989;66:219-223.
42. Tanaka S, Nemoto K, Yamamura E, Ichikawa A. Intracellular localization of the 74- and 53-kDa forms of L-histidine decarboxylase in a rat basophilic/mast cell line, KBL-2H3. J. Biol. Chem. 1998;273:8177-8182.
43. Durham SR. The ideal nasal corticosteroid: balancing efficacy, safety and patient preference. Clin. Exp. All. Rev. 2002;2:32-37.